Cargando…

Editorial: Genomics of Lymphoproliferative Disease

Detalles Bibliográficos
Autores principales:	Maura, Francesco, Agnelli, Luca, Bortoluzzi, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010244/ https://www.ncbi.nlm.nih.gov/pubmed/33816317 http://dx.doi.org/10.3389/fonc.2021.660016

Ejemplares similares

Lack of Viral Load Within Chronic Lymphoproliferative Disorder of Natural Killer Cells: What Is Outside the Leukemic Clone?
por: Giussani, Edoardo, et al.
Publicado: (2021)

Treatment Advances in EBV Related Lymphoproliferative Diseases
por: Lv, Kebing, et al.
Publicado: (2022)

Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
por: Hui, Kwai Fung, et al.
Publicado: (2019)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
por: Shindiapina, Polina, et al.
Publicado: (2020)

Adult-Onset Still’s Disease With Extensive Lymphadenopathy Mimicking Lymphoproliferative Malignancy
por: Paul, Mishouri, et al.
Publicado: (2021)

Dysregulation of FBW7 in malignant lymphoproliferative disorders
por: Wan, Xin, et al.
Publicado: (2022)

The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases
por: Vigliotta, Ilaria, et al.
Publicado: (2022)

Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy
por: Küçük, Can, et al.
Publicado: (2020)

Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact
por: Ferla, Valeria, et al.
Publicado: (2020)

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
por: Barros, Mario Henrique M., et al.
Publicado: (2023)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
por: Crombie, Jennifer L., et al.
Publicado: (2019)

Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
por: Pearce, David R., et al.
Publicado: (2023)

Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study
por: Lückemeier, Philipp, et al.
Publicado: (2023)

Successful Treatment of Central Nervous System Post-Transplant Lymphoproliferative Disease With a Reduced Dose of High-Dose Methotrexate
por: Albusoul, Linda, et al.
Publicado: (2022)

Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders
por: Butzmann, Alexandra, et al.
Publicado: (2022)

Erratum: Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study
Publicado: (2023)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

Localized light chain amyloidosis: A self-limited plasmacytic B-cell lymphoproliferative disorder
por: Martínez, José C., et al.
Publicado: (2022)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Editorial: Infections and posttransplant lymphoproliferative disease after pediatric kidney transplantation
por: Kizilbash, Sarah J., et al.
Publicado: (2023)

Editorial: New strategies to tackle chemoresistance in cancer
por: De Marco, Carmela, et al.
Publicado: (2022)

Editorial: State of the art body composition profiling: Advances in imaging modalities and patient outcomes
por: Petrella, Francesco, et al.
Publicado: (2022)

Editorial: Measurable residual disease in hematologic malignancies
por: Buccisano, Francesco, et al.
Publicado: (2023)

Malignant Lymphoproliferative Diseases
por: Garrett, J. V.
Publicado: (1981)

Cardiovascular and Lymphoproliferative Diseases
por: Huston, Sharon M., et al.
Publicado: (2004)

Editorial: Inflammation and blood diseases, a dog chasing its tail
por: Cumbo, Cosimo, et al.
Publicado: (2023)

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Yang, Ting-Ting, et al.
Publicado: (2021)

Editorial: HBV and lymphoma
por: Gentile, Giuseppe, et al.
Publicado: (2023)

Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation
por: Teramo, Antonella, et al.
Publicado: (2022)

Editorial: Bone Metastases
por: Valenti, Maria Teresa, et al.
Publicado: (2021)

Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
por: Yan, Nan, et al.
Publicado: (2021)

Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report
por: Dimassi, Ahmad B, et al.
Publicado: (2020)

Post-transplant lymphoproliferative disease
por: Dharnidharka, Vikas R., et al.
Publicado: (2009)

Editorial: Reviews in hematologic malignancies
por: Saraceni, Francesco, et al.
Publicado: (2022)

A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells
por: Gasparini, Vanessa Rebecca, et al.
Publicado: (2020)

Editorial: Reviews in genitourinary oncology
por: Arcangeli, Stefano, et al.
Publicado: (2023)

Editorial: Genomics and Epigenomics of Cancer Immunotherapy: Challenges and Clinical Implications
por: Abedalthagafi, Malak
Publicado: (2021)

Editorial: Implementation of genomic and epigenomic innovation in clinical cancer diagnostics
por: Schenkel, Laila C., et al.
Publicado: (2023)

Editorial: Current understanding of genomic and chromosomal instabilities in solid malignancies
por: Vodicka, Pavel, et al.
Publicado: (2023)

Editorial: Understanding leukemia biology using genome editing techniques
por: Jimenez-Morales, Silvia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jpojqh8ionddicbotmuqngfp5u